Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases-Reference-Cited by-同舟云学术

Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases

Published:2020-10 Issue:10 Volume:46 Page:1925-1931
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Hulshof E.C.,Lurvink R.J.^ORCID,Caserta N.,de Hingh I.H.J.T.,van Wezel T.^ORCID,Böhringer S.^ORCID,Swen J.J.,Gelderblom H.,Guchelaar H.J.,Deenen M.J.

Funder

Catharina Onderzoeksfonds, the Netherlands

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference34 articles.

1. Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: results of a population-based study;Razenberg;Eur J Canc,2016

2. Peritoneal carcinomatosis from colorectal cancer;Jayne;Br J Surg,2002

3. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in The Netherlands;Razenberg;Eur J Surg Oncol,2015

4. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer;Verwaal;J Clin Oncol,2003

5. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

2. Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy;Frontiers in Oncology;2022-03-08

3. Determination of whether HIPEC is beneficial in patients with synchronous peritoneal and liver metastases from colorectal cancer (Review);Experimental and Therapeutic Medicine;2021-09-07

4. Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review;Frontiers in Pharmacology;2020-10-06